Rest assured, our team of specialists is here to guide you through every stage of your wellness journey, providing support and advice whenever needed
2b the data was inadvertently shifted upwards and has now been corrected in the HTML and PDF versions of the article
FDA-Approved vs Research Compounds Understanding the distinction between FDA-approved peptides and research-only compounds is essential for evaluating safety: Category Examples Evidence Base Regulation FDA-Approved Semaglutide (Ozempic), Teriparatide (Forteo), Tesamorelin (Egrifta) Phase I-III clinical trials, post-market surveillance Prescription required, manufactured under cGMP Previously Approved Sermorelin (Geref withdrawn 2008) Clinical trial data exists, but product no longer marketed Research use only (currently) Research Only BPC-157, TB-500, Ipamorelin, KPV Preclinical data (varying depth), no completed human trials Sold for laboratory research, not human consumption For the complete list of FDA-approved peptides and their indications, see our FDA Approved Peptides List 2026 guide

Research Applications Comprehensive tissue repair and regeneration research Musculoskeletal injury healing studies Tendon and ligament repair research Muscle injury recovery studies Wound healing and tissue remodeling research Angiogenesis and vascularization studies Post-surgical healing research Inflammation modulation studies Sports medicine and athletic injury research Connective tissue repair studies Safety Profile The safety profile of the BPC-157 + TB-500 blend draws from the individual safety data of each component